<DOC>
	<DOCNO>NCT00918710</DOCNO>
	<brief_summary>High risk papillomavirus ( HR-HPV ) oncogenic role Oropharyngeal squamous cell carcinoma ( OP-SCC ) least 25 % case prevalence increase . HPV+ might chemo radio sensible good prognosis ( disease-free survival ( DFS ) overall survival ( OS ) compare HPV negative OP-SCC ; hypothesis : 2y DFS &gt; 20 % improvement ) . The principal objective determine impact status HR-HPV prognosis OP-SCC . The principal criterion 2-years DFS . Secondary objective : virologic characteristic HPV+ tumor .</brief_summary>
	<brief_title>Human Papillomavirus Oropharynx Carcinoma</brief_title>
	<detailed_description>The study impact treatment observed population . The clinical study include TNM status , previous story HPV infection , smoke alcoholic habit , treatment outcome 5 year . The virologic study include : HPV type , E6-E7 viral charge HPV16 , viral DNA integration tumoral genome , HPV16 variant , expression HPV 16 , 18 , 31 , 45 coding oncoproteins E6-E7 mRNA . Moreover serologic study do .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<criteria>Squamous cell carcinoma Oropharynx proven histologically All stag TNM inform consent No previous simultaneous Head Neck cancer Age &gt; 18 Squamous cell carcinoma oropharynx 2nd synchronous SCC localization No consent age &lt; 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Squamous cell carcinoma Oropharynx</keyword>
	<keyword>Human papillomavirus .</keyword>
	<keyword>Biological prognostic marker .</keyword>
</DOC>